OCT 05, 2016 10:30 AM PDT

Unraveling the Complexities of Immuno-Oncology with 3D Biology™ Technology

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Senior Vice President of Research and Development, NanoString Technologies
      Since April 2012, Joe Beechem has led NanoString Technologies in its pursuit of next-generation immune-oncology. With deep expertise in genetic analysis, sequencing, and research, Dr. Beechem has directed the design and development of multiple genetic analysis technologies including various sequencing platforms.
    • Chief Medical Officer, NanoString Technologies
        Alessandra Cesano is a leading expert in the field of immune-oncology. With more than 20 years of experience in R&D, management, and tumor immunology, she plays a key role in providing the overall clinical vision for NanoString Technologies as the organization continues to ignite new discoveries in cancer research.


      The ability to measure changes to DNA, RNA, and protein across cell types is crucial to understanding the immune response to the environment or therapeutic treatment. NanoString Technologies has pioneered the concept of 3D Biology: the ability to measure DNA, RNA, and protein simultaneously using a single detector from a small sample, allowing precise characterization of these complex interactions. Join our presentation and learn more about 3D Biology Technology.

      Show Resources
      Loading Comments...